You are searching for: Phase 2 Trial

T97729
Target Info
Target Name HUMAN two pore channel subtype 2 (TPC2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Amiodarone Drug Info
T99009
Target Info
Target Name HUMAN dihydroorotate dehydrogenase (DHODH)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS)
Drugs IMU-838 Drug Info
T94501
Target Info
Target Name HUMAN complement C5 alpha (C5A)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs IFX-1 Drug Info
T94307
Target Info
Target Name HUMAN interferon gamma (IFNG)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Emapalumab Drug Info
T99993
Target Info
Target Name HUMAN vascular endothelial growth factor (VEGF)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Bevacizumab Drug Info
T87374
Target Info
Target Name COVID-19 spike glycoprotein (S)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Nafamostat Drug Info
T99908
Target Info
Target Name HUMAN transmembrane protease serine 2 (TMPRSS2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS)
Drugs Camostat mesylate Drug Info
T98390
Target Info
Target Name HUMAN angiotensin-converting enzyme 2 (ACE2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19); Severe acute respiratory syndrome (SARS)
Drugs rhACE2 Drug Info
T00099
Target Info
Target Name HUMAN calpain-1/calpain small subunit 1 heterodimer (CAPN1/CAPNS1)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs BLD-2660 Drug Info
T86837
Target Info
Target Name HUMAN calpain-2/calpain small subunit 1 heterodimer (CAPN2/CAPNS1)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs BLD-2660 Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.